chemotherapyadvisor.com | Cancer Articles, News & Research Info | Treatment & Drug Trials

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔

Meta Tags

Title	Cancer Articles, News & Research Info \| Treatment & Drug Trials - Cancer Therapy
Description	Latest cancer articles, treatment info, research news and more for oncologists and medical professionals. Read featured content on cancer research, treatment regimens and clinical studies delivered to your
Keywords	N/A

Server Information

WebSite	chemotherapyadvisor.com
Host IP	165.160.13.20
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

chemotherapyadvisor.com Valuation

US$903,820

Last updated: 2023-05-16 01:40:31

chemotherapyadvisor.com has Semrush global rank of 11,710,638. chemotherapyadvisor.com has an estimated worth of US$ 903,820, based on its estimated Ads revenue. chemotherapyadvisor.com receives approximately 104,287 unique visitors each day. Its web server is located in United States, with IP address 165.160.13.20. According to SiteAdvisor, chemotherapyadvisor.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$903,820
Daily Ads Revenue	US$835
Monthly Ads Revenue	US$25,029
Yearly Ads Revenue	US$300,347
Daily Unique Visitors	6,953
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
chemotherapyadvisor.com. 300	A	chemotherapyadvisor.com. 300	IP: 165.160.13.20
chemotherapyadvisor.com. 300	A	chemotherapyadvisor.com. 300	IP: 165.160.15.20
chemotherapyadvisor.com. 86400	NS	chemotherapyadvisor.com. 86400	NS Record: love.ns.cloudflare.com.
chemotherapyadvisor.com. 86400	NS	chemotherapyadvisor.com. 86400	NS Record: jasper.ns.cloudflare.com.
chemotherapyadvisor.com. 300	MX	chemotherapyadvisor.com. 300	MX Record: 10 aspmx2.googlemail.com.
chemotherapyadvisor.com. 300	MX	chemotherapyadvisor.com. 300	MX Record: 10 aspmx3.googlemail.com.
chemotherapyadvisor.com. 300	MX	chemotherapyadvisor.com. 300	MX Record: 5 alt1.aspmx.l.google.com.
chemotherapyadvisor.com. 300	MX	chemotherapyadvisor.com. 300	MX Record: 5 alt2.aspmx.l.google.com.
chemotherapyadvisor.com. 300	MX	chemotherapyadvisor.com. 300	MX Record: 1 aspmx.l.google.com.
chemotherapyadvisor.com. 300	MX	chemotherapyadvisor.com. 300	MX Record: 53 haymarketmedia.com.s200b2.psmtp.com.
chemotherapyadvisor.com. 300	MX	chemotherapyadvisor.com. 300	MX Record: 52 haymarketmedia.com.s200b1.psmtp.com.
chemotherapyadvisor.com. 300	MX	chemotherapyadvisor.com. 300	MX Record: 51 haymarketmedia.com.s200a2.psmtp.com.
chemotherapyadvisor.com. 300	MX	chemotherapyadvisor.com. 300	MX Record: 50 haymarketmedia.com.s200a1.psmtp.com.
chemotherapyadvisor.com. 300	TXT	chemotherapyadvisor.com. 300	TXT Record: google-site-verification=y_zC32-Gj2fPbEYwCAWFQF1mLashwS7ETCenFg0ZcR4
chemotherapyadvisor.com. 300	TXT	chemotherapyadvisor.com. 300	TXT Record: v=spf1 include:mailgun.org include:_spf.google.com ~all

HtmlToTextCheckTime:2023-05-16 01:40:31

Skip to navigation Menu Close Search... Submit Breast CML Gastrointestinal GYN Lung Multiple Myeloma Prostate RCC Skin More Open Submenu More Back Bladder Cancer Bone Cancer Brain Cancer Chronic Lymphocytic Leukemia Endocrine Cancer General Medicine General Oncology Head and Neck Cancer Hematologic Cancers Lymphoma Pancreatic Cancer Pediatric Cancer Practice Management Sarcoma Supportive Care Urologic Cancers Toggle Search Menu Headlines Drugs Conferences Clinical Resources Tools Multimedia CME Jobs Login Register Get the App Submit Cases Top News Cancer Patients Report Better Experiences With Telemedicine Than With In-Person Care Cancer Patients With Diabetes May Have Worse Outcomes on ICIs HIPEC With Mitomycin C Improves Locoregional Control in Colon Cancer 1999 to 2018 Saw Increase in Cancer Survivors With Functional Limitations Screening Recommendations for Women at Increased Risk of Breast Cancer AUA, SUO Issue New Guideline on Nonmetastatic UTUC Draft USPSTF Guidance Recommends

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Mon, 17 Jan 2022 08:27:03 GMT
Location: http://www.cancertherapyadvisor.com/
Content-Length: 0
X-ORACLE-DMS-ECID: ab8cfbc6-bbb9-4867-90b0-a750d1a71bb4-4dd402a7
X-ORACLE-DMS-RID: 0

HTTP/1.1 301 Moved Permanently
Date: Mon, 17 Jan 2022 08:27:04 GMT
Connection: keep-alive
Cache-Control: max-age=3600
Expires: Mon, 17 Jan 2022 09:27:04 GMT
Location: https://www.cancertherapyadvisor.com/
Server: cloudflare
CF-RAY: 6cee33c60d824a74-FRA

HTTP/2 200 
date: Mon, 17 Jan 2022 08:27:04 GMT
content-type: text/html; charset=UTF-8
cf-ray: 6cee33c75a434ea3-FRA
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
vary: Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie,X-WPENGINE-SEGMENT
cf-cache-status: DYNAMIC
x-frame-options: SAMEORIGIN
x-distributor: yes
x-powered-by: WP Engine
x-cacheable: SHORT
x-cache: HIT: 1
x-cache-group: normal
x-wpengine-segment: NONHT
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server: cloudflare

chemotherapyadvisor.com Whois Information

Domain Name: CHEMOTHERAPYADVISOR.COM
Registry Domain ID: 1682565914_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: http://cscdbs.com
Updated Date: 2021-10-13T05:10:21Z
Creation Date: 2011-10-17T13:24:04Z
Registry Expiry Date: 2023-10-17T13:24:04Z
Registrar: CSC Corporate Domains, Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email: domainabuse@cscglobal.com
Registrar Abuse Contact Phone: 8887802723
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: JASPER.NS.CLOUDFLARE.COM
Name Server: LOVE.NS.CLOUDFLARE.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-01-17T07:49:45Z <<<

chemotherapyadvisor.com valuation and analysis